Long term (current) drug therapy (Z79)
The Z79 ICD-10 codes specify long term (current) drug therapy used to indicate ongoing medication treatment for various conditions. These codes are applied when patients use medications such as anticoagulants, steroids, insulin, or immunosuppressants over an extended period.
The Z79 section includes detailed subcodes reflecting specific long-term drug uses. For example, Z79.01 covers long-term anticoagulant use, often referenced by terms like "history of pulmonary embolism on long-term anticoagulation therapy" or "requires lifelong warfarin therapy." Similarly, Z79.4 represents long-term insulin use for diabetes management. Codes like Z79.51 and Z79.52 differentiate between inhaled and systemic steroids, while Z79.6 and its subcodes identify prolonged use of immunomodulators and immunosuppressants, including biologics and calcineurin inhibitors. Other subcodes address long-term uses of antibiotics, hormonal contraceptives, chemotherapeutic agents, and various specialized drugs such as selective estrogen receptor modulators (Z79.810) or aspirin therapy (Z79.82). Using these specific ICD-10 codes helps accurately document patients’ chronic medication regimens for clinical and billing purposes.
- Z79 - Long term (current) drug therapy
- Z79.0 - Long term (current) use of anticoagulants and antith
- Z79.5 - Long term (current) use of steroids
- Z79.6 - Long term (current) use of immunomodulators and immu
- Z79.62 - Long term (current) use of immunosuppressant
- Z79.63 - Long term (current) use of chemotherapeutic agent
- Z79.8 - Other long term (current) drug therapy
- Z79.81 - Long term (current) use of agents affecting estroge
- Z79.89 - Other long term (current) drug therapy
Factors influencing health status and contact with health services (Z00–Z99)
Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
Z79 Long term (current) drug therapy
Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets
- Z79.01 Long term (current) use of anticoagulants
- Z79.02 Long term (current) use of antithrombotics/antiplatelets
- Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID)
- Z79.2 Long term (current) use of antibiotics
- Z79.3 Long term (current) use of hormonal contraceptives
- Z79.4 Long term (current) use of insulin
Z79.5 Long term (current) use of steroids
- Z79.51 Long term (current) use of inhaled steroids
- Z79.52 Long term (current) use of systemic steroids
Z79.6 Long term (current) use of immunomodulators and immunosuppressants
- Z79.60 Long term (current) use of unspecified immunomodulators and immunosuppressants
- Z79.61 Long term (current) use of immunomodulator
Z79.62 Long term (current) use of immunosuppressant
- Z79.620 Long term (current) use of immunosuppressive biologic
- Z79.621 Long term (current) use of calcineurin inhibitor
- Z79.622 Long term (current) use of Janus kinase inhibitor
- Z79.623 Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
- Z79.624 Long term (current) use of inhibitors of nucleotide synthesis
Z79.63 Long term (current) use of chemotherapeutic agent
- Z79.630 Long term (current) use of alkylating agent
- Z79.631 Long term (current) use of antimetabolite agent
- Z79.632 Long term (current) use of antitumor antibiotic
- Z79.633 Long term (current) use of mitotic inhibitor
- Z79.634 Long term (current) use of topoisomerase inhibitor
- Z79.64 Long term (current) use of myelosuppressive agent
- Z79.69 Long term (current) use of other immunomodulators and immunosuppressants
Z79.8 Other long term (current) drug therapy
Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels
- Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
- Z79.811 Long term (current) use of aromatase inhibitors
- Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
- Z79.82 Long term (current) use of aspirin
- Z79.83 Long term (current) use of bisphosphonates
- Z79.84 Long term (current) use of oral hypoglycemic drugs
- Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs
Z79.89 Other long term (current) drug therapy
- Z79.890 Hormone replacement therapy
- Z79.891 Long term (current) use of opiate analgesic
- Z79.899 Other long term (current) drug therapy
Long term (current) drug therapy (Z79)
Instructional Notations
Includes
This note appears immediately under a three character code title to further define, or give examples of, the content of the category.
- long term (current) drug use for prophylactic purposes
Code Also
A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- any therapeutic drug level monitoring Z51.81
Type 2 Excludes
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.
- drug abuse and dependence F11 F19
- drug use complicating pregnancy, childbirth, and the puerperium O99.32
Clinical Terms
The following clinical terms provide additional context, helping users better understand the clinical background and common associations for each diagnosis listed in this section. Including related terms alongside ICD-10-CM codes supports coders, billers, and healthcare professionals in improving accuracy, enhancing documentation, and facilitating research or patient education.
Estrogen Replacement Therapy
The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.
Hormone Replacement Therapy
Therapeutic use of hormones to alleviate the effects of hormone deficiency.